Acasă › Leucemie limfatică cronică › District of Columbia › Washington
Studii clinice pentru Leucemie limfatică cronică în Washington, DC
22 studii pentru Leucemie limfatică cronică caută participanți în și în jurul orașului Washington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
În curs de recrutareFaza 1/2
- American Oncology Partners of Maryland Pa, Bethesda · La 7 mi distanță
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
În curs de recrutareFaza 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · La 7 mi distanță
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
În curs de recrutareFaza 3
- GC2202 Study Site 111, Bethesda · La 7 mi distanță
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
În curs de recrutareFaza 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
În curs de recrutareFaza 3
- American Oncology Partners of Maryland Pa, Bethesda · La 7 mi distanță
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
În curs de recrutareFaza 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
În curs de recrutareFaza 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · La 7 mi distanță
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
În curs de recrutareFaza 2
- Maryland Oncology Hematology, Silver Spring · La 7 mi distanță
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
În curs de recrutareFaza 1 timpurie
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
În curs de recrutareFaza 3
- American Oncology Partners of Maryland, PA, Bethesda · La 7 mi distanță
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
În curs de recrutareFaza 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · La 7 mi distanță
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
În curs de recrutareFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- National Institute of Health, Bethesda · La 7 mi distanță
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
În curs de recrutareFaza 2
- American Oncology Partners, PA, Bethesda · La 7 mi distanță
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
În curs de recrutareFaza 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · La 7 mi distanță
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · La 7 mi distanță
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Studii pentru Leucemie limfatică cronică în alte orașe
- Boston, MA31 studii
- Columbus, OH28 studii
- Durham, NC27 studii
- Seattle, WA20 studii
- Rochester, MN18 studii
- New York City, NY18 studii
- Houston, TX17 studii
- Baldwin Park, CA16 studii
- Milwaukee, WI15 studii
- Chicago, IL14 studii
- Cincinnati, OH14 studii
- Nashville, TN13 studii
Alte studii în Washington
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate55 studii
- Cancer de sân46 studii
- Cancer metastatic43 studii
- Cancer pulmonar41 studii
- Cancer de prostată38 studii
- Obezitate33 studii
- Cancer colorectal29 studii
- Boli cardiovasculare28 studii
- Cancer de vezică urinară26 studii
- Leucemie mieloasă acută24 studii
- Cancer ovarian23 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.